Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/7783
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kasimova S.A., Axatov Sh.Sh., Babadjanova Sh.A. | - |
dc.date.accessioned | 2023-05-10T16:21:08Z | - |
dc.date.available | 2023-05-10T16:21:08Z | - |
dc.date.issued | 2023-04 | - |
dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/7783 | - |
dc.description.abstract | In connection with the above, a burdened family history of metabolic syndrome (especially if there is a phenotypic similarity between the patient and a relative with MS) can be regarded as a risk factor for the complication of "steroid diabetes mellitus". Patients assigned to this group, if dexamethasone is necessary, should be pre-tested for glucose tolerance and subsequently their blood glucose levels should be effectively monitored during program treatment . | en_US |
dc.language.iso | other | en_US |
dc.publisher | KLINIK LABORATOR DIAGNOSTIKADA INNOVATSION TEXNOLOGIYALARDAN FOYDALANISH, MUAMMOLAR VA YECHIMLAR | en_US |
dc.relation.ispartofseries | №2; | - |
dc.subject | Leukemia,lymphoblastic leukemia,glucocorticosteroid hormones,diabetes mellitus | en_US |
dc.title | Frequency of occurrence of steroid diabetes mellitus on the background of acute leukemia | en_US |
dc.type | Thesis | en_US |
Appears in Collections: | Thesis, Articles |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.